These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19539541)

  • 21. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
    Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
    Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
    Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertrophic cardiomyopathy: never-ending complexity].
    Navarro-López F
    Rev Esp Cardiol; 2006 Oct; 59(10):994-6. PubMed ID: 17125707
    [No Abstract]   [Full Text] [Related]  

  • 25. Cranial, axial and proximal myopathy and hypertrophic cardiomyopathy caused by a mutation in the globular head region of the MYH7 gene.
    Díaz-Manera J; Alejaldre A; Llauger J; Mirabet S; Rojas-García R; Ramos-Fransi A; Gallardo E; Illa I
    Eur J Neurol; 2014 Jun; 21(6):e51-2. PubMed ID: 24805292
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
    Tajsharghi H; Fyhr IM
    Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.
    Castellana S; Mastroianno S; Palumbo P; Palumbo O; Biagini T; Leone MP; De Luca G; Potenza DR; Amico CM; Mazza T; Russo A; Di Stolfo G; Carella M
    J Electrocardiol; 2019; 53():95-99. PubMed ID: 30716529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole Exome Sequencing Identified a 13 Base Pair
    Fan LL; Guo S; Jin JY; He ZJ; Zhao SP; Xiang R; Zhao W
    Ann Clin Lab Sci; 2019 Nov; 49(6):838-840. PubMed ID: 31882438
    [No Abstract]   [Full Text] [Related]  

  • 30. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy.
    Tsuda T; Hayashi K; Konno T; Sakata K; Fujita T; Hodatsu A; Nagata Y; Teramoto R; Nomura A; Tanaka Y; Furusho H; Takamura M; Kawashiri MA; Fujino N; Yamagishi M
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1136-1142. PubMed ID: 29759496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 35. End-stage Hypertrophic Cardiomyopathy with Advanced Heart Failure in Patients Carrying MYH7 R453 Variants: A Case Series.
    Naito S; Higo S; Kameda S; Ogawa S; Tabata T; Akazawa Y; Nakamura D; Nakamoto K; Sera F; Kuramoto Y; Asano Y; Hikoso S; Miyagawa S; Sakata Y
    Intern Med; 2023 Nov; 62(21):3167-3173. PubMed ID: 36948619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Dias GM; Lamounier Júnior A; Seifert M; Barájas-Martinez H; Barr D; Sternick EB; Medina-Acosta E; Campos de Carvalho AC; Cruz Filho FES
    Circ Genom Precis Med; 2021 Oct; 14(5):e003476. PubMed ID: 34555931
    [No Abstract]   [Full Text] [Related]  

  • 38. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy.
    O'Mahony C; Jichi F; Monserrat L; Ortiz-Genga M; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27217341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.